We are live on ! Find out more
CRGX

CARGO Therapeutics

Delisted

CRGX was delisted on the 18th of August, 2025.

73 hedge funds and large institutions have $716M invested in CARGO Therapeutics in 2024 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 31 increasing their positions, 16 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

100% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 9

94% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 16

12% more funds holding

Funds holding: 6573 (+8)

2.68% more ownership

Funds ownership: 92.45%95.13% (+2.7%)

12% less capital invested

Capital invested by funds: $812M → $716M (-$95.6M)

Holders
73
Holders Change
+8
Holders Change %
+12.31%
% of All Funds
1.05%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
18
Increased
31
Reduced
16
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Mirae Asset Global ETFs Holdings
51
Mirae Asset Global ETFs Holdings
Hong Kong
$211K +$245K +12,912 New
MIM
52
MetLife Investment Management
New Jersey
$204K +$22.1K +1,162 +10%
Citigroup
53
Citigroup
New York
$203K -$588K -30,939 -71%
CF
54
Corebridge Financial
Texas
$173K +$201K +10,563 New
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$171K -$5.02K -264 -2%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$143K +$68.9K +3,623 +71%
JP Morgan Chase
57
JP Morgan Chase
New York
$141K +$2.72K +143 +2%
Wells Fargo
58
Wells Fargo
California
$138K +$25.4K +1,337 +19%
VEA
59
Virtus ETF Advisers
New York
$86.5K +$100K +5,269 New
TRCT
60
Tower Research Capital (TRC)
New York
$65.6K +$39.6K +2,082 +109%
AIP
61
Ameritas Investment Partners
Nebraska
$35.2K
BNP Paribas Financial Markets
62
BNP Paribas Financial Markets
France
$34.9K -$162K -8,537 -80%
Royal Bank of Canada
63
Royal Bank of Canada
Ontario, Canada
$30K +$26K +1,365 +283%
AB
64
Amalgamated Bank
New York
$12K
Russell Investments Group
65
Russell Investments Group
United Kingdom
$6.29K +$7.28K +383 New
AP
66
Atwood & Palmer
Missouri
$5.75K
Pacer Advisors
67
Pacer Advisors
Pennsylvania
$3.78K +$95 +5 +2%
US Bancorp
68
US Bancorp
Minnesota
$3.73K +$4.32K +227 New
AF
69
Allworth Financial
California
$2.61K
Macquarie Group
70
Macquarie Group
Australia
$1.13K +$1.31K +69 New
Nisa Investment Advisors
71
Nisa Investment Advisors
Missouri
$558 +$532 +28 +467%
PBA
72
Paradigm Biocapital Advisors
New York
-$3.3M -147,959 Closed
SC
73
Stempoint Capital
New York
-$1.14M -51,126 Closed
Invesco
74
Invesco
Georgia
-$1.12M -50,064 Closed
Millennium Management
75
Millennium Management
New York
-$644K -28,845 Closed

CRGX Hedge Fund Activity: Q2 2024 in Review

73 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in CARGO Therapeutics (CRGX) for Q2 2024, worth a combined $716M — down 12% from $812M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new CRGX positions and 9 closed out — a net gain of 9 holders — while 31 added to existing stakes and 16 trimmed.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $27.9M. The largest seller was Paradigm Biocapital Advisors, exiting entirely with an estimated $3.3M sold.

  • 73 institutional investors held CARGO Therapeutics (CRGX) as of Q2 2024, up from 65 in Q1 2024.
  • Funds reported $716M of CARGO Therapeutics stock for Q2 2024, down 12% quarter-over-quarter.
  • 18 funds opened new CARGO Therapeutics positions in Q2 2024 and 9 closed out, a net change of +9 holders.
  • The largest CARGO Therapeutics buyer in Q2 2024 was EcoR1 Capital, an estimated $27.9M added.
  • The largest CARGO Therapeutics seller in Q2 2024 was Paradigm Biocapital Advisors, an estimated $3.3M sold.

Based on aggregated 13F filings for Q2 2024.